The AmLaw Litigation Daily highlighted Finnegan attorneys Charles Lipsey, John Livingstone, Jill MacAlpine, David Weingarten, Ryan O’Quinn, Matt Hlinka, and Megan Meyers for their District of Delaware bench trial win on behalf of client AstraZeneca. The ruling protected AstraZeneca’s FARXIGA drug products against generic competition, stating the opposition failed to prove AstraZeneca’s patent claims were invalid due to obviousness.
Commentary
May 20, 2026
Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Award/Ranking
Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey
May 7, 2026
Announcement
Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International
May 4, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.